title: Reducing the risk of endophthalmitis after intravitreous injection.
authors.affiliation: Vanderbilt Eye Institute, Vanderbilt University Medical Center, Nashville, TN 37232, USA. skim30@gmail.com
authors.forename: Stephen J
authors.initials: SJ
authors.lastname: Kim
authors.forename: Amy S
authors.initials: AS
authors.lastname: Chomsky
authors.forename: Paul
authors.initials: P
authors.lastname: Sternberg
mesh_terms: D020533:Angiogenesis Inhibitors / Q000008:administration & dosage*; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D003228:Conjunctiva / Q000382:microbiology; D004340:Drug Contamination / Q000517:prevention & control; D009877:Endophthalmitis / Q000382:microbiology / Q000517:prevention & control*; D015818:Eye Infections, Bacterial / Q000382:microbiology / Q000517:prevention & control*; D005143:Eyelids / Q000382:microbiology; D006801:Humans; D058449:Intravitreal Injections / Q000592:standards; D009883:Ophthalmic Solutions; D011206:Povidone-Iodine / Q000627:therapeutic use; D012307:Risk Factors; D014822:Vitreous Body / Q000382:microbiology
chemical_list: D020533:Angiogenesis Inhibitors; D000900:Anti-Bacterial Agents; D009883:Ophthalmic Solutions; D011206:Povidone-Iodine